Patent · US Active

HTT modulators for treating Huntington's disease

US11806346B2 · kind B2 · utility

1Cited by
7References
37Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 12, 2021
Grant dateNov 7, 2023
Priority date
Expiry dateMay 12, 2041

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D519/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided herein are certain compounds useful as HTT modulators. Such compound are useful in the treatment of Huntington's disease.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.